XD9D:SW:SW-Xtrackers MSCI USA UCITS ETF 1D (USD)

ETF | Others |

Last Closing

USD 20.53

Change

-0.04 (-0.19)%

Market Cap

USD 0.14B

Volume

1.24K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHSRIA:SW UBS ETF (CH) MSCI Switzerland ..

+0.19 (+0.95%)

USD 492,935.36B
XLDX:SW Xtrackers LevDAX Daily Swap UC..

+3.92 (+2.42%)

USD 411,075.38B
CHSRI:SW UBS ETF (CH) - MSCI Switzerlan..

+0.17 (+0.94%)

USD 368,190.74B
XNIF:SW Xtrackers Nifty 50 Swap UCITS ..

-0.05 (-0.02%)

USD 292,109.69B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.08 (+0.37%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+55.00 (+1.16%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+17.40 (+1.17%)

USD 134,034.86B

ETFs Containing XD9D:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.16% 55% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.16% 54% F 56% F
Trailing 12 Months  
Capital Gain 26.95% 86% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.95% 85% B 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.37% 84% B 82% B
Dividend Return 7.37% 84% B 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.61% 25% F 33% F
Risk Adjusted Return 63.48% 90% A- 90% A-
Market Capitalization 0.14B 51% F 46% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.